TITLE

Neoadjuvant chemotherapy in stage IIIa non-small cell lung cancer

AUTHOR(S)
Milroy, R; Macbeth, F
PUB. DATE
September 1995
SOURCE
Thorax;Sep1995 Supp, Vol. 50, pS25
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
66026050

 

Related Articles

  • Randomized, Prospective Trial of Customized Neoadjuvant versus Standard Chemotherapy Gets Underway. Buckley, Rita // MD Conference Express;Jun2014, Vol. 14 Issue 3, p14 

    The first prospective, multicenter, randomized Phase 2 study to test the use of customized chemotherapy (CT) in locally advanced stage IIIA (N2) non—small cell lung cancer (NSCLC) is currently recruiting patients. The rationale and design of the Customized Neoadjuvant Versus Standard...

  • Chimiothérapie pré-opératoire des cancers bronchiques non à petites cellules. Moro-Sibilot, D.; Diab, S.; Fourneret, P.; Aubert, A. // Oncologie;oct2005, Vol. 7 Issue 6, p451 

    The five-year survival rates for patients with non-small cell lung cancer (NSCLC) ranges from 9 to 61% following resection, depending on clinical stage; survival rates post-surgery (pathologic stage) range from 25 to 67%. Surgical resection remains the standard of care in early stage NSCLC,...

  • Surgery.  // Current Medical Literature: Lung Cancer;2012, Vol. 6 Issue 2, p39 

    This section presents clinical reviews related to surgical intervention in treatment of lung cancer. One study suggests surgical resection for stage I and II small cell carcinoma of the lung. Details on a phase 3 study of induction treatment with concurrent chemotherapy versus chemotherapy...

  • Carboplatin/cetuximab/paclitaxel.  // Reactions Weekly;5/28/2011, Issue 1353, p10 

    The article describes the case of a 72-year-old woman with Stage IIIa non-small cell lung cancer who developed confusion, aggressive behavior and paranoia after completing chemotherapy with carboplatin, cetuximab and paclitaxel.

  • Adjuvant chemotherapy for elderly patients with lung cancer.  // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;7/30/2011, Vol. 343 Issue 7817, p243 

    The article presents the findings of a study by Juan Wisnivesky and team on the efficacy of adjuvant platinum based chemotherapy for older patients with Non-small cell lung cancer at stages I to IIIA which reveals that chemotherapy improves survival in patients above 65 years of age.

  • Even the Deadliest Lung Cancers Can Be Treated. Begany, Timothy // Pulmonary Reviews;Jan2007, Vol. 12 Issue 1, p29 

    Information about the emerging therapies for lung cancer discussed at CHEST 2006 in Salt Lake City, Utah on October 23, 2006, is presented. Vitezslav Kolek discussed his study of neoadjuvant/adjuvant combination chemotherapy for staeg IIIA non-small cell lung cancer. Brian T. Collins and his...

  • Highlights in management of early stage non-small cell lung cancer. Li, Grace // Journal of Thoracic Disease;Aug2013 Supplement, Vol. 5, pS339 

    The article reports that the journal "Translational Lung Cancer Research" will launch its special issue entitled "Management of Early Stage Non-Small Cell Lung Cancer." It highlights the topics of this special issue which include the treatment for Non-Small Cell Lung Cancer (NSCLC), role of...

  • Highlights in lung cancer: explore treatment and care for lung cancer with world-known experts. Li, Grace // Journal of Thoracic Disease;Aug2013 Supplement, Vol. 5, pS337 

    The article reports that the journal "Translational Lung Cancer Research" will launch its special issue entitled "Management of Early Stage Non-Small Cell Lung Cancer." It highlights the topics of this special issue which include the treatment for Non-Small Cell Lung Cancer (NSCLC), role of...

  • Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer. Felip, Enriqueta; Rosell, Rafael // Current Medicinal Chemistry;Apr2002, Vol. 9 Issue 8, p893 

    Non-small cell lung cancer (NSCLC) is a systemic illness. More than half of those patients who present with stage I-IIIA disease and are resected will experience distant relapse. Postoperative adjuvant chemotherapy has been evaluated in several randomized trials but the results of these trials...

  • Neoadjuvant chemotherapy and concomitant boost radiotherapy in locally advanced non-small cell lung cancer. Meydan, Denız; Çkir, Şaban; Özbek, Nılgün; Gürsel, Bılge; Karaoğlanoğlu, Özden // Turkish Journal of Cancer;Oct2006, Vol. 36 Issue 4, p162 

    This Phase II study was designed to assess the possibility of increasing local control and decreasing distant metastasis by using neoadjuvant chemotherapy, and concomitant boost radiotherapy which was used to prevent accelerated repopulation in locally advanced non-small cell lung cancer....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics